NCT02057380 2024-11-20A Rollover Study for Subjects That Have Participated in an Astellas Sponsored Linsitinib TrialAstellas Pharma IncPhase 2 Completed13 enrolled
NCT00402766 2015-11-18Cisplatin, Pemetrexed, and Imatinib Mesylate in Malignant MesotheliomaM.D. Anderson Cancer CenterPhase 1 Completed19 enrolled